Alnylam Pharmaceuticals
ALNY
#645
Rank
C$44.15 B
Marketcap
$342.36
Share price
-0.77%
Change (1 day)
53.44%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company